“Hospitals lose billions annually to denied claims. Aerolib AI is turning the tide by bringing intelligent automation, ...

Dr. Anosh Ahmed announces an expansion of his COVID-19 testing services, with new COVID testing contracts now secured and ...

Ceribell also filed a complaint with the U.S. District Court in Delaware asserting infringement of the same patents. Ceribell initiated litigation because it believes Natus is infringing six of its ...

Vincerx is urging ALL stockholders to vote IMMEDIATELY FOR the Dissolution Proposal. Vincerx’s board of directors unanimously recommends that stockholders vote FOR the Dissolution Proposal and ...

The inducement grant is subject to the terms and conditions of award agreements and the company’s 2025 Inducement Stock Incentive Plan. About Generation Bio Generation Bio is a biotechnology company ...

The inducement grant consisted of time-based restricted stock units (“RSUs”) for 23,800 shares of Intellia’s common stock, with one-third of such RSUs vesting on July 1, 2026, 2027 and 2028.

In response to President Donald J. Trump’s recent remarks about conditions in Chicago, Dr. Anosh Ahmed, a Chicago-based ...

A live question and answer session will follow the presentation. The recording of the presentation and Q&A will be available under the investor section of the FibroBiologics website after the event.

In parallel, Nanobiotix has filed a new composition of matter patent for JNJ-1900 (NBTXR3) that aims to reinforce the intellectual property foundation supporting the product candidate.

The Annual Meeting will be reconvened on Monday, July 21, 2025, at 9:30 a.m. Mountain Time, and will continue to be held at the Company’s corporate office at 8181 Arista Place, Suite 100, Broomfield, ...

This milestone payment follows the successful settlement of the second tranche of €115.6 million 1 in gross proceeds (net proceeds of €108.5 million) of the previously announced structured financing ...

Ascendis is making important advances in its growing Endocrinology Rare Disease portfolio,” said Aimee Shu, M.D., Executive Vice President of Endocrine & Rare Disease Medical Sciences and Chief ...